# POEMS syndrome with cardiovascular lesions as the initial manifestation: a case report and literature review

**Authors:** Xiuwei Tan, Gaowei Fan, Jiateng Yao, Changwei Lu, Zhaojie Qin

PMC · DOI: 10.3389/fcvm.2026.1716667 · Frontiers in Cardiovascular Medicine · 2026-01-30

## TL;DR

A case of POEMS syndrome initially presented with cardiovascular issues, highlighting the importance of early diagnosis for better outcomes.

## Contribution

This case report emphasizes the atypical initial manifestation of POEMS syndrome and underscores the need for accurate diagnostic strategies.

## Key findings

- POEMS syndrome initially presented as cardiovascular dysfunction, leading to delayed diagnosis.
- Treatment with chemotherapy and symptomatic care significantly reduced symptoms and improved function.
- Elevated vascular endothelial growth factor levels and osteolytic lesions confirmed the diagnosis.

## Abstract

Polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, and skin changes (POEMS) syndrome is frequently mistaken for chronic inflammatory demyelinating polyneuropathy, as its clinical profile is highly variable and neurological symptoms often dominate the initial course. In the present case, the disorder initially presented as cardiovascular dysfunction, which delayed decision-making related to the original diagnosis. As the condition advanced, the patient developed progressive limb weakness, splenomegaly, and abnormalities in lipid metabolism. Whole-body bone scintigraphy revealed osteolytic lesions in association with a plasmacytoma, whereas the serum vascular endothelial growth factor levels were markedly elevated. Based on the cumulative findings, POEMS syndrome was diagnosed. Treatment with interventional chemotherapy combined with adjunctive symptomatic care resulted in a marked reduction in symptoms and promoted functional recovery. This case provides detailed clinical evidence highlighting the critical importance of early recognition and accurate diagnostic evaluation in POEMS syndrome. By aligning our observations with the existing literature, we emphasize strategies that promote timely diagnosis, minimize diagnostic error, and improve therapeutic outcomes.

## Linked entities

- **Diseases:** POEMS syndrome (MONDO:0017364), chronic inflammatory demyelinating polyneuropathy (MONDO:0006702), plasmacytoma (MONDO:0005615)

## Full-text entities

- **Genes:** VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}
- **Diseases:** limb weakness (MESH:D018908), Polyneuropathy (MESH:D011115), chronic inflammatory demyelinating polyneuropathy (MESH:D020277), syndrome (MESH:D013577), skin changes (MESH:D012871), osteolytic lesions (MESH:D030981), splenomegaly (MESH:D013163), plasmacytoma (MESH:D010954), endocrinopathy (MESH:C567425), cardiovascular dysfunction (MESH:D002318), POEMS (MESH:D016878), abnormalities in lipid metabolism (MESH:D052439)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12901498/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12901498/full.md

## References

35 references — full list in the complete paper: https://tomesphere.com/paper/PMC12901498/full.md

---
Source: https://tomesphere.com/paper/PMC12901498